Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Castro

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Experimental Cell Research|December 15, 2007
Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximideG Brumatti, M Yon, F A Castro, et al.
Scientific Reports|May 31, 2022
Estimation of milk yield based on udder measures of Pelibuey sheep using artificial neural networksJ C Angeles-Hernandez, F A Castro-Espinoza, A Peláez-Acero, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patientsM C Souza, C A Rodrigues, M R R Silva, et al.
BMC Nephrology|April 18, 2015
Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function managementRenata P Assis, Juliana F A Castro, Vânia O Gutierres, et al.
Blood Cells, Molecules & Diseases|March 18, 2014
ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistanceA F Ferreira, L G Moura, I Tojal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Journal of Clinical Pathology|July 13, 2016
Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosisL G Moura, R Tognon, N S Nunes, et al.
Oncogene|September 15, 2010
BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patientsD D De Carvalho, R Binato, W O Pereira, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Experimental Cell Research|December 15, 2007
Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximideG Brumatti, M Yon, F A Castro, et al.
Scientific Reports|May 31, 2022
Estimation of milk yield based on udder measures of Pelibuey sheep using artificial neural networksJ C Angeles-Hernandez, F A Castro-Espinoza, A Peláez-Acero, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patientsM C Souza, C A Rodrigues, M R R Silva, et al.
BMC Nephrology|April 18, 2015
Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function managementRenata P Assis, Juliana F A Castro, Vânia O Gutierres, et al.
Blood Cells, Molecules & Diseases|March 18, 2014
ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistanceA F Ferreira, L G Moura, I Tojal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Journal of Clinical Pathology|July 13, 2016
Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosisL G Moura, R Tognon, N S Nunes, et al.
Oncogene|September 15, 2010
BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patientsD D De Carvalho, R Binato, W O Pereira, et al.
Pageof 2